![Roy Gonzales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Gonzales
Keine laufenden Positionen mehr
Profil
Mr. Roy M.
Gonzales was previously employed as a Chief Financial & Accounting Officer by Ventyx Biosciences, Inc., a Vice President-Finance by Landos Biopharma, Inc., and a Vice President-Finance & SEC Reporting by Histogen, Inc. He received his undergraduate degree from Old Dominion University, an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from the University of California, Los Angeles.
Ehemalige bekannte Positionen von Roy Gonzales
| Unternehmen | Position | Ende |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Finanzdirektor/CFO | 04.03.2026 |
| LANDOS BIOPHARMA, INC. | Corporate Officer/Principal | 01.06.2022 |
| HISTOGEN INC. | Corporate Officer/Principal | 01.09.2021 |
Ausbildung von Roy Gonzales
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
 Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
 Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Histogen, Inc.
 Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
